The supply chain financing platform has filed to raise up to $1.06bn in a Hong Kong Stock Exchange offering which will enable Bertelsmann, GLP, Skyworth and Tencent to exit.

The online question-and-answer platform developer is going public alongside a $250m private placement featuring JD.com, Alibaba, Tencent and Lilith Games.

Hanwha and SoftBank could exit the advanced biomaterials developer in the offering, which will follow more than $870m in funding.

BioLife Solutions will issue more than 6.6 million shares to acquire Ohio University-affiliated Stirling Ultracold in an all-stock transaction.

The University of Utah spinout is looking to float on the Nasdaq Global Select Market and has filed with a $100m placeholder amount.

The SoftBank-backed automotive e-commerce platform developer priced its initial public offering above the range and hit a $4.8bn valuation yesterday.

Cambridge Enterprise is celebrating another win with the acquisition of Smap Energy by Enechange.

The gene therapy developer focused on cardiovascular and central nervous system diseases will merge with Chardan Healthcare Acquisition 2 Corp to list on NYSE.

The Petronas and TNSC-backed 3D printing tedchnology provider has agreed to list through a reverse takeover deal at a $1.6bn valuation.

Bayer could exit the drug discovery technology developer should it complete an initial public offering on the Nasdaq Global Select Market.